West Health



Medicare considers covering expensive Alzheimer’s drug for those in clinical trials

NPR’s Morning Edition discussed a proposal announced on January 11, which Medicare would cover the expensive and controversial Alzheimer’s drug Aduhelm — but only for those participating in clinical trials. West Health Policy Director Sean Dickson was interviewed in the segment: “It’s not something that we as taxpayers should be paying for if it’s not actually going to help people.” Listen to the the full segment from NPR’s Morning Edition.